ClinicalTrials.govpublic full text
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
high-risk neuroblastoma, patient with insufficient response chemoimmunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 454032
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.